Company Registration No. 02343479 (England and Wales)
PROFUSION LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
PROFUSION LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
PROFUSION LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
75,508
105,724
Tangible assets
4
38,913
24,478
Investments
5
-
0
8,000
114,421
138,202
Current assets
Stocks
1,150,373
1,079,158
Debtors
6
1,007,204
887,065
Cash at bank and in hand
416,153
280,071
2,573,730
2,246,294
Creditors: amounts falling due within one year
7
(1,111,577)
(759,131)
Net current assets
1,462,153
1,487,163
Total assets less current liabilities
1,576,574
1,625,365
Creditors: amounts falling due after more than one year
8
(15,000)
(75,000)
Net assets
1,561,574
1,550,365
Capital and reserves
Called up share capital
60,669
60,669
Profit and loss reserves
1,500,905
1,489,696
Total equity
1,561,574
1,550,365
PROFUSION LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 9 June 2026 and are signed on its behalf by:
K Persin
MD Persin
Director
Director
Company registration number 02343479 (England and Wales)
PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Profusion Limited is a private company limited by shares incorporated in England and Wales. The registered office is 4 T A H House, Aviation Way, Southend-on-Sea, Essex, SS2 6UN.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
5 years straight line
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following straight line bases:

Leasehold improvements
Straight line basis over the remaining term of the lease
Fixtures and fittings
15% Straight line basis
Office equipment
25% Straight line basis
Motor vehicles
25% Straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Fixed asset investments

Unlisted investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in profit or loss. Transaction costs are expensed to profit or loss as incurred.

 

In some cases a market value is not attainable and when such cases occur the investments are recognised at cost and annually reviewed for impairment.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Trade debtors, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as 'loans and receivables'. Loans and receivables are measured at amortised cost using the effective interest method, less any impairment.

 

Interest is recognised by applying the effective interest rate, except for short-term receivables when the recognition of interest would be immaterial. The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating the interest income over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the debt instrument to the net carrying amount on initial recognition.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
11
11
PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
3
Intangible fixed assets
Software
£
Cost
At 1 January 2025 and 31 December 2025
151,083
Amortisation and impairment
At 1 January 2025
45,359
Amortisation charged for the year
30,216
At 31 December 2025
75,575
Carrying amount
At 31 December 2025
75,508
At 31 December 2024
105,724
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025
33,884
176,127
210,011
Additions
-
0
27,952
27,952
Disposals
(810)
(67,847)
(68,657)
At 31 December 2025
33,074
136,232
169,306
Depreciation and impairment
At 1 January 2025
30,836
154,697
185,533
Depreciation charged in the year
971
11,204
12,175
Eliminated in respect of disposals
(810)
(66,505)
(67,315)
At 31 December 2025
30,997
99,396
130,393
Carrying amount
At 31 December 2025
2,077
36,836
38,913
At 31 December 2024
3,048
21,430
24,478
PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
-
0
8,000
Financial assets for which fair value cannot be measured reliably

A minority investment in an unlisted trading company totalling £8,000 has been accounted for at cost less impairment as its fair value cannot be measured reliably due to the lack of an active market and comparable transactions.

6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
701,221
850,862
Other debtors
59,186
32,057
760,407
882,919
2025
2024
Amounts falling due after more than one year:
£
£
Other debtors
244,477
4,146
Deferred tax asset
2,320
-
0
246,797
4,146
Total debtors
1,007,204
887,065
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
60,000
60,000
Trade creditors
710,549
599,685
Taxation and social security
65,122
58,923
Other creditors
275,906
40,523
1,111,577
759,131
PROFUSION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
15,000
75,000
9
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
34,000
51,000
10
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Company under common control
240,120
-
Other information

In addition to the above balance, there are amounts due from a company under common control totaling £23,643. This amount is included within trade debtors. There are also amounts owed to a company under common control totaling £8,398. This amount is included within trade creditors.

2025-12-312025-01-01falsefalsefalse09 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityK PersinMD PersinMD Persin023434792025-01-012025-12-31023434792025-12-31023434792024-12-3102343479core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-12-3102343479core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-12-3102343479core:LandBuildings2025-12-3102343479core:OtherPropertyPlantEquipment2025-12-3102343479core:LandBuildings2024-12-3102343479core:OtherPropertyPlantEquipment2024-12-3102343479core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3102343479core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3102343479core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3102343479core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3102343479core:CurrentFinancialInstruments2025-12-3102343479core:CurrentFinancialInstruments2024-12-3102343479core:ShareCapital2025-12-3102343479core:ShareCapital2024-12-3102343479core:RetainedEarningsAccumulatedLosses2025-12-3102343479core:RetainedEarningsAccumulatedLosses2024-12-3102343479bus:Director12025-01-012025-12-3102343479bus:CompanySecretaryDirector12025-01-012025-12-3102343479core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3102343479core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-01-012025-12-3102343479core:LeaseholdImprovements2025-01-012025-12-3102343479core:FurnitureFittings2025-01-012025-12-3102343479core:ComputerEquipment2025-01-012025-12-3102343479core:MotorVehicles2025-01-012025-12-31023434792024-01-012024-12-3102343479core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-12-3102343479core:LandBuildings2024-12-3102343479core:OtherPropertyPlantEquipment2024-12-31023434792024-12-3102343479core:LandBuildings2025-01-012025-12-3102343479core:OtherPropertyPlantEquipment2025-01-012025-12-3102343479core:AfterOneYear2025-12-3102343479core:AfterOneYear2024-12-3102343479core:Non-currentFinancialInstruments2025-12-3102343479core:Non-currentFinancialInstruments2024-12-3102343479bus:PrivateLimitedCompanyLtd2025-01-012025-12-3102343479bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3102343479bus:FRS1022025-01-012025-12-3102343479bus:AuditExemptWithAccountantsReport2025-01-012025-12-3102343479bus:Director22025-01-012025-12-3102343479bus:CompanySecretary12025-01-012025-12-3102343479bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP